website statistics

Thank you for visting YOLO Medical Inc!
Please select your region below.

Regulatory Status of YOLO MEDICAL Inc. Lapex BCS, Lucia & YOLO Curve:
The Lapex 2000 510(k) (k034009), Lapex BCS 510(k)(k081962), Lucia 510(k)(k102375) and YOLO Curve 510(k)(k110324) are cleared by USFDA with indication intended to emit energy in the visible and infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain, or muscle spasm; the temporary increase in local blood circulation; and/or the temporary relaxation of muscle.

According to FDA guidelines, devices can only be promoted, advertised and marketed for the indication that they are approved for.

For additional information, contact the FDA directly at: 1.888.463.6332 or visit them online at www.fda.gov.

  I have read and understand the above statement.

DPA (Digital Pulse Analyzer) by Yolo Medical Inc.

Innovative Tools
For a Healthier You


You are seeing this text because you don't have an appropriate Flash Player to view it. You need Flash Player 8 or later to view the Flash items of this site. If you are sure you have Flash 8 or later and you have JavaScript enabled you can click here to bypass the detection.

DIGITAL PULSE ANALYZER (DPA):
NON INVASIVE - USER FRIENDLY - SCREENING TECHNOLOGY

Digital Pulse Analyzer (DPA)Healthy arteries are flexible and elastic –unhealthy arteries are often stiff or hard and cannot expand–which places extra strain on the heart to pump blood throughout the rest of the body.

The Digital Pulse Analyzer uses non invasive, pulse wave technology to look at arterial elasticity which is an important preventative measure in overall cardiovascular health. The DPA collects and presents data on arterial wall stiffness and determines the biological age of arteries in less than three minutes. The DPA also comes with Heart Rate Variability software that analyzes imperceptible changes in the heart rate waveforms. Low HRV has been linked to higher mortality rates in both health and unhealthy patients, thus it can be a strong predicator of all-cause mortality.

The DPA can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention. The DPA can also monitor the effectiveness of treatment modalities-whether they are lifestyle changes such as exercise supplementation or pharmaceutical medications. If a particular treatment is effective, you will see an improvement in your DPA test.

Cardiovascular disease continues to be the number one killer for both men & women throughout North America. Yolo believes that the use of the DPA can help reduce cardiovascular disease through early detection and prevention, and ultimately decrease the financial costs placed on the health care industry and stressed placed on family and friends.

WE ALL KNOW SOMEONE WHOS IS AT RISK OF CARDIOVASCULAR DISEASE.